SAKAR HEALTHCARE
Back to Cashflow Statement
|
SAKAR HEALTHCARE Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-3.48 Cr | ₹27 Cr | ₹41 Cr | ₹55 Cr | ₹32 Cr |
What is the latest Cash Flow from Financing Activities ratio of SAKAR HEALTHCARE ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-3.48 Cr |
| Mar2024 | ₹27 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹55 Cr |
| Mar2021 | ₹32 Cr |
How is Cash Flow from Financing Activities of SAKAR HEALTHCARE Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-3.48 Cr | Negative | |
| Mar2024 | ₹27 Cr | -33.22 | |
| Mar2023 | ₹41 Cr | -24.76 | |
| Mar2022 | ₹55 Cr | 70.51 | |
| Mar2021 | ₹32 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹1,884.3 Cr | 2% | 4.4% | 127.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 2% |
4.4% |
127.9% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses